vs
Enovis CORP（ENOV）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
Enovis CORP的季度营收约是RBC Bearings INC的1.2倍（$548.9M vs $461.6M），RBC Bearings INC净利率更高（14.6% vs -104.1%，领先118.7%），RBC Bearings INC同比增速更快（17.0% vs -2.2%），RBC Bearings INC自由现金流更多（$99.1M vs $29.1M），过去两年Enovis CORP的营收复合增速更高（9.8% vs 5.6%）
Enovis是一家专注于骨科领域的医疗科技企业，其前身是1995年由米切尔·雷尔斯和史蒂文·雷尔斯兄弟创立的科尔法克斯公司。公司总部位于特拉华州威尔明顿，目前在全球12个地点开展业务，拥有超过5000名员工，于纽约证券交易所上市，股票代码为ENOV。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
ENOV vs RBC — 直观对比
营收规模更大
ENOV
是对方的1.2倍
$461.6M
营收增速更快
RBC
高出19.2%
-2.2%
净利率更高
RBC
高出118.7%
-104.1%
自由现金流更多
RBC
多$70.0M
$29.1M
两年增速更快
ENOV
近两年复合增速
5.6%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $548.9M | $461.6M |
| 净利润 | $-571.1M | $67.4M |
| 毛利率 | 59.9% | 44.3% |
| 营业利润率 | -101.7% | 22.3% |
| 净利率 | -104.1% | 14.6% |
| 营收同比 | -2.2% | 17.0% |
| 净利润同比 | 18.8% | 16.4% |
| 每股收益（稀释后） | $-9.99 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENOVRBC
| Q4 25 | $548.9M | $461.6M | ||
| Q3 25 | $564.5M | $455.3M | ||
| Q2 25 | $558.8M | $436.0M | ||
| Q1 25 | — | $437.7M | ||
| Q4 24 | $561.0M | $394.4M | ||
| Q3 24 | $505.2M | $397.9M | ||
| Q2 24 | $525.2M | $406.3M | ||
| Q1 24 | $516.3M | $413.7M |
净利润ENOVRBC
| Q4 25 | $-571.1M | $67.4M | ||
| Q3 25 | $-36.7M | $60.0M | ||
| Q2 25 | $-56.0M | $68.5M | ||
| Q1 25 | — | $72.7M | ||
| Q4 24 | $-703.2M | $57.9M | ||
| Q3 24 | $-31.5M | $54.2M | ||
| Q2 24 | $-18.6M | $61.4M | ||
| Q1 24 | $-72.0M | — |
毛利率ENOVRBC
| Q4 25 | 59.9% | 44.3% | ||
| Q3 25 | 59.3% | 44.1% | ||
| Q2 25 | 59.5% | 44.8% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | 54.8% | 44.3% | ||
| Q3 24 | 56.7% | 43.7% | ||
| Q2 24 | 55.0% | 45.3% | ||
| Q1 24 | 57.7% | 43.1% |
营业利润率ENOVRBC
| Q4 25 | -101.7% | 22.3% | ||
| Q3 25 | -3.0% | 21.5% | ||
| Q2 25 | -8.4% | 23.2% | ||
| Q1 25 | — | 23.0% | ||
| Q4 24 | -118.5% | 21.7% | ||
| Q3 24 | -6.3% | 21.6% | ||
| Q2 24 | -8.4% | 24.0% | ||
| Q1 24 | -6.8% | 22.8% |
净利率ENOVRBC
| Q4 25 | -104.1% | 14.6% | ||
| Q3 25 | -6.5% | 13.2% | ||
| Q2 25 | -10.0% | 15.7% | ||
| Q1 25 | — | 16.6% | ||
| Q4 24 | -125.4% | 14.7% | ||
| Q3 24 | -6.2% | 13.6% | ||
| Q2 24 | -3.5% | 15.1% | ||
| Q1 24 | -13.9% | — |
每股收益（稀释后）ENOVRBC
| Q4 25 | $-9.99 | $2.13 | ||
| Q3 25 | $-0.64 | $1.90 | ||
| Q2 25 | $-0.98 | $2.17 | ||
| Q1 25 | — | $2.33 | ||
| Q4 24 | $-12.69 | $1.82 | ||
| Q3 24 | $-0.58 | $1.65 | ||
| Q2 24 | $-0.34 | $1.90 | ||
| Q1 24 | $-1.32 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.6M | $107.6M |
| 总债务越低越好 | $1.4B | $990.2M |
| 股东权益账面价值 | $2.0B | $3.3B |
| 总资产 | $4.4B | $5.1B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ENOVRBC
| Q4 25 | $33.6M | $107.6M | ||
| Q3 25 | $44.1M | $91.2M | ||
| Q2 25 | $38.5M | $132.9M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | $48.2M | — | ||
| Q3 24 | $35.4M | — | ||
| Q2 24 | $35.0M | $76.8M | ||
| Q1 24 | $66.3M | $63.5M |
总债务ENOVRBC
| Q4 25 | $1.4B | $990.2M | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.4B | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | $1.2B |
股东权益ENOVRBC
| Q4 25 | $2.0B | $3.3B | ||
| Q3 25 | $2.6B | $3.2B | ||
| Q2 25 | $2.6B | $3.1B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | $2.6B | $2.9B | ||
| Q3 24 | $3.3B | $2.9B | ||
| Q2 24 | $3.3B | $2.8B | ||
| Q1 24 | $3.3B | $2.8B |
总资产ENOVRBC
| Q4 25 | $4.4B | $5.1B | ||
| Q3 25 | $5.0B | $5.1B | ||
| Q2 25 | $4.9B | $4.8B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | $4.7B | $4.7B | ||
| Q3 24 | $5.6B | $4.7B | ||
| Q2 24 | $5.4B | $4.7B | ||
| Q1 24 | $5.5B | $4.7B |
负债/权益比ENOVRBC
| Q4 25 | 0.67× | 0.30× | ||
| Q3 25 | 0.54× | 0.34× | ||
| Q2 25 | 0.53× | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | 0.40× | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.6M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $29.1M | $99.1M |
| 自由现金流率自由现金流/营收 | 5.3% | 21.5% |
| 资本支出强度资本支出/营收 | 9.7% | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | $22.8M | — |
8季度趋势，按日历期对齐
经营现金流ENOVRBC
| Q4 25 | $82.6M | $122.1M | ||
| Q3 25 | $47.8M | $88.4M | ||
| Q2 25 | $-1.6M | $120.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | $88.3M | $84.0M | ||
| Q3 24 | $53.6M | — | ||
| Q2 24 | $7.8M | $97.4M | ||
| Q1 24 | $-36.2M | — |
自由现金流ENOVRBC
| Q4 25 | $29.1M | $99.1M | ||
| Q3 25 | $3.4M | $71.7M | ||
| Q2 25 | $-44.9M | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | $35.1M | $73.6M | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $-31.6M | $88.4M | ||
| Q1 24 | $-73.1M | — |
自由现金流率ENOVRBC
| Q4 25 | 5.3% | 21.5% | ||
| Q3 25 | 0.6% | 15.7% | ||
| Q2 25 | -8.0% | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.3% | 18.7% | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | -6.0% | 21.8% | ||
| Q1 24 | -14.2% | — |
资本支出强度ENOVRBC
| Q4 25 | 9.7% | 5.0% | ||
| Q3 25 | 7.9% | 3.7% | ||
| Q2 25 | 7.7% | 3.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | 9.5% | 2.6% | ||
| Q3 24 | 10.1% | 4.1% | ||
| Q2 24 | 7.5% | 2.2% | ||
| Q1 24 | 7.2% | — |
现金转化率ENOVRBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
